The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > REGULATORY
REGULATORY
- MHLW’s Study Committee on Clinical Research Systems to Hold 1st Meeting on April 17
April 10, 2014
- PMDA Announces Ongoing Evaluation of Benambax for Risk of Severe Bradycardia
April 9, 2014
- FPMAJ Not Giving Up on Perpetuation of Premium for New Drug Development: Committee Chair
April 9, 2014
- MHLW, MEXT, and METI Map Out New 10-Year Strategy for Cancer Research
April 8, 2014
- Ministry Panel Starts Reviewing Five-Year Promotion Plan for Clinical Research
April 8, 2014
- Japan NIH to Kick in with 300 Workers, 200 of Them on Contract
April 7, 2014
- Novartis’ Cover-Up Attempt over SIGN Trial “Outrageous”: Minister
April 7, 2014
- PMDA Opens New Office to Prepare for Introduction of CDISC Standards
April 4, 2014
- MHLW Sets New Target Review Periods for Diagnostics to Speed up Regulatory Processes
April 2, 2014
- PMDA to Boost Workforce to 1,065 in Five Years
April 2, 2014
- MHLW to Set Up Council on Measures Against Counterfeit Drugs with Lifting of Ban on Online OTC Drug Sales
April 2, 2014
- PMDA to Conduct Pharmacokinetic Analysis in Pilot Study on Electronic NDA Submissions
April 1, 2014
- Lower House Panels to Begin Deliberations on Japanese NIH-Related Bills
April 1, 2014
- PMDA Announces Results of Pilot Study on Electronic NDA Submissions Using CDISC Standards
April 1, 2014
- Mixed Care to Be Boosted in Tokyo, Kansai Special Economic Zones: Panel
March 31, 2014
- Govt Deregulation Panel Pushes New System to Allow Mixed Care at Patient Request
March 31, 2014
- MHLW to Set Up Study Group on Clinical Research Legislation in April: Minister Tamura
March 31, 2014
- Science Council of Japan Recommends Establishment of Clinical Research Promotion Center at PMDA
March 31, 2014
- Fulminant Hepatitis Added to Precautions Section of Package Insert for Regorafenib: MHLW Safety Information
March 31, 2014
- MHLW Panel Concludes Novartis Systematically Involved in Diovan Trials: Report
March 28, 2014
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…